Corvex (MOVE) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
14 Aug, 2026Executive summary
Completed merger with Corvex Legacy Holdings/OpCo on March 19, 2026, marking the first full quarter including the AI cloud computing business and exit from legacy healthcare assets as of June 30, 2026.
AI platform specializes in GPU-accelerated infrastructure, offering AI factories, Token Factory (inference platform), and confidential computing, with early-stage commercialization and ongoing infrastructure expansion.
Revenue for Q2 2026 was $3.8 million, all from the AI platform and services, under fixed-term contracts.
Contracted annualized recurring revenue (ARR) on live compute reached approximately $22 million as of August 2026.
Significant leadership appointments and board expansions were made to strengthen operational and governance capabilities.
Financial highlights
Q2 2026 revenue: $3.8 million; six-month revenue: $4.3 million (from March 19 to June 30).
Net loss for Q2: $12.8 million; net loss attributable to common stockholders: $12.8 million; six-month net loss: $17.8 million.
Adjusted EBITDA for Q2: -$3.2 million; for six months: -$4.8 million; AI platform and services contributed -$2.3 million for Q2.
Stock-based compensation expense was $9.7 million for Q2 2026, $11.9 million for the six months.
Ended quarter with $21.7 million in cash and cash equivalents.
Outlook and guidance
Focus on expanding contracted power and compute capacity to meet growing demand and scaling Token Factory.
Management expects continued net losses as investments in AI infrastructure and personnel continue.
Existing cash is expected to fund operations for at least the next twelve months; additional capital may be sought for future growth.
Key metrics for future reporting: contracted power, contracted ARR on live compute, and capacity brought into service.
Ongoing investments in automation and reliability to accelerate AI innovation.
Latest events from Corvex
- AI cloud platform registers 53.4M shares for resale, with no new capital raised and high dilution risk.MOVE
Registration filing - All proposals, including board expansion and stock plans, were approved as the company pivots to AI.MOVE
AGM 2026 - Shareholders to approve director elections, share issuances, equity plans, and auditor after a major merger.MOVE
Proxy filing - Proxy seeks approval for merger-related equity, new plans, and board elections, with full board support.MOVE
Proxy filing - Q1 2026 revenue rose 148% to $510K, with pro forma revenue at $3.7M after the AI-focused merger.MOVE
Q1 2026 - Merger completed, AI focus established, healthcare sales paused, FY2025 net loss $18.3M on $0.4M revenue.MOVE
Q4 2025 - 2024 revenue grew to $1.0M, but ongoing losses and cash needs raise going concern risks.MOVE
Q4 2024 - Corvex's merger creates a leading AI cloud platform, with shareholders owning 95% of the new entity.MOVE
Registration filing - AI cloud merger enables $1B equity facility, positioning for growth amid high risk.MOVE
Registration filing